Investigational Site Number : 1560036

Shenyang 110016

1 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Heart Failure, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype — Recruiting now
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early